Metropolis Healthcare Share Price in Focus as Promoters Sell 1.01 Percent Stake Worth Rs 118.44 Crore at Rs 564 With Aditya Birla SL MF and Morgan Stanley as Buyers on 12 August 2026

The Metropolis Healthcare share price is in focus on 12 August 2026 after promoter entities Duru Shah Family Trust and Metz Advisory LLP each sold 10.5 lakh shares for Rs 59.22 crore at Rs 564 per share in a large block deal. The combined promoter sale represented a 1.01 percent stake in Metropolis Healthcare for a total transaction value of Rs 118.44 crore. The Metropolis Healthcare share price block deal was matched by three high-quality institutional buyers: Aditya Birla Sun Life Mutual Fund, ICICI Prudential Mutual Fund, and Morgan Stanley Asia Singapore Pte, all of whom absorbed the supply at the Rs 564 Metropolis Healthcare share price without a significant discount.

The Metropolis Healthcare share price block deal is noteworthy for the quality of institutional buyers who stepped in. Aditya Birla Sun Life Mutual Fund, which already held a 1.95 percent stake in Metropolis Healthcare as of June 2026 through its Flexi Cap Fund, purchased an additional 10.49 lakh shares for Rs 59.16 crore. This incremental purchase at the Rs 564 Metropolis Healthcare share price indicates that Aditya Birla Sun Life views the current valuation as attractive for adding to an existing position. ICICI Prudential Mutual Fund and Morgan Stanley Asia Singapore each bought 5.25 lakh shares for Rs 29.63 crore at the same Metropolis Healthcare share price level.

Click Here – Get Free Investment Predictions

Metropolis Healthcare Share Price Block Deal: Who Sold and Who Bought

Participant	Role	Shares (Lakh)	Price	Value
Duru Shah Family Trust	Seller (Promoter)	10.50	Rs 564	Rs 59.22 crore
Metz Advisory LLP	Seller (Promoter)	10.50	Rs 564	Rs 59.22 crore
Aditya Birla Sun Life MF	Buyer (Institution)	10.49	Rs 564	Rs 59.16 crore
ICICI Prudential MF	Buyer (Institution)	5.25	Rs 564	Rs 29.63 crore
Morgan Stanley Asia Singapore	Buyer (Institution)	5.25	Rs 564	Rs 29.63 crore

Metropolis Healthcare Share Price: What This Means for Investors

The Metropolis Healthcare share price block deal structure is broadly positive for retail investors tracking the stock. When promoters sell and domestic mutual funds as well as a global institutional investor like Morgan Stanley Asia Singapore simultaneously absorb the block at the same Metropolis Healthcare share price without any discount, it signals strong secondary market demand at the Rs 564 level. This full-price institutional absorption of the promoter block is a better outcome for the Metropolis Healthcare share price than a discounted block that creates an immediate price overhang.

Aditya Birla Sun Life Flexi Cap Fund's existing 1.95 percent stake in Metropolis Healthcare before this transaction means that after the additional 10.49 lakh share purchase, ABSL's total Metropolis Healthcare share price exposure has meaningfully increased. This sustained and growing institutional commitment suggests the fund manager is constructive on the Metropolis Healthcare share price outlook over the medium term based on the diagnostics sector recovery and the company's specific financial trajectory.

Research Metropolis Healthcare Share Price and Healthcare Sector Stocks on Univest

Download the Univest iOS App or Univest Android App to track the Metropolis Healthcare share price and healthcare sector institutional activity.

Conclusion

The Metropolis Healthcare share price is in focus on 12 August 2026 as promoters sold a 1.01 percent stake worth Rs 118.44 crore at Rs 564 per share. Aditya Birla Sun Life MF (adding to its existing 1.95% stake), ICICI Prudential MF, and Morgan Stanley Asia Singapore absorbed the full block at the same Metropolis Healthcare share price. The quality of institutional buyers and the absence of any price discount are positive signals for the stock. Investors should track the company's diagnostics sector fundamentals and consult a SEBI-registered advisor before investing based on the Metropolis Healthcare share price.

Frequently Asked Questions

What is the Metropolis Healthcare share price today?

Ans. The Metropolis Healthcare share price is in focus on 12 August 2026 after promoter entities Duru Shah Family Trust and Metz Advisory LLP each sold 10.5 lakh shares at Rs 564 per share for Rs 59.22 crore each. The combined promoter sale totalled Rs 118.44 crore representing a 1.01 percent stake in Metropolis Healthcare. Investors should check the live Metropolis Healthcare share price on NSE or BSE.

Who sold Metropolis Healthcare shares in the block deal?

Ans. Promoter entities Duru Shah Family Trust and Metz Advisory LLP each sold 10.5 lakh shares of Metropolis Healthcare for Rs 59.22 crore at Rs 564 per share. The combined sale represented a 1.01 percent stake in Metropolis Healthcare. Together the two promoter sellers offloaded a total of 21 lakh shares worth Rs 118.44 crore in the block deal at the Rs 564 Metropolis Healthcare stock.

Who bought Metropolis Healthcare shares in the block deal?

Ans. Aditya Birla Sun Life Mutual Fund acquired 10.49 lakh shares for Rs 59.16 crore. ICICI Prudential Mutual Fund and Morgan Stanley Asia Singapore Pte each bought 5.25 lakh shares for Rs 29.63 crore. As of June 2026, Aditya Birla Sun Life Flexi Cap Fund already held a 1.95 percent stake in Metropolis Healthcare, making this an addition to an existing position at the Rs 564 The diagnostics stock.

What is the total value of the Metropolis Healthcare block deal?

Ans. The Metropolis Healthcare block deal totalled Rs 118.44 crore based on promoter sellers Duru Shah Family Trust and Metz Advisory LLP each selling 10.5 lakh shares for Rs 59.22 crore at Rs 564 per share. Three institutional buyers absorbed this supply: Aditya Birla Sun Life MF, ICICI Prudential MF, and Morgan Stanley Asia Singapore. The Rs 118.44 crore total reflects two-sided institutional activity at the current Metropolis shares.

Is promoter selling in Metropolis Healthcare a negative sign?

Ans. Promoter selling of 1.01 percent in Metropolis Healthcare at Rs 564 is partially offset by strong institutional buying interest from three high-quality buyers including Aditya Birla Sun Life MF, ICICI Prudential MF, and Morgan Stanley Asia Singapore. The fact that institutional buyers absorbed the entire promoter block at the Rs 564 The stock without requiring a significant discount is a positive sign for the stock's institutional demand at current levels.

What does Metropolis Healthcare do?

Ans. Metropolis Healthcare is one of India's leading diagnostic laboratory chains, providing pathology testing services including blood tests, imaging, and specialised diagnostics through a network of labs across India. The Metropolis Healthcare stock reflects the company's revenue from test volumes, pricing trends in the diagnostics sector, network expansion, and competition from peers like Dr Lal PathLabs, Thyrocare, and Vijaya Diagnostic.

What is the long-term outlook for the The diagnostics stock?

Ans. The Metropolis shares long-term outlook depends on the diagnostics sector volume recovery from the high COVID-era base, the company's expansion into Tier 2 and Tier 3 cities, digital platform development for home collection services, and margin improvement. Aditya Birla Sun Life Flexi Cap's existing 1.95 percent stake and additional buying at Rs 564 suggests institutional confidence in the The stock at current valuation levels. Consult a SEBI-registered advisor before investing.